SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
明亮依琴
Lv5
880 积分
2024-04-18 加入
最近求助
最近应助
互助留言
Characterization of a high‐affinity human antibody with a disulfide bridge in the third complementarity‐determining region of the heavy chain
9天前
已完结
Affinity-matured antibody with a disulfide bond in H-CDR3 loop
9天前
已完结
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
15天前
已完结
Development of a robust reporter gene assay to measure the bioactivity of anti-PD-1/anti-PD-L1 therapeutic antibodies
18天前
已完结
Pharmacology and Pharmacokinetics of NXT007; Emicizumab-Based Engineered Fixa/Fx Bispecific Antibody with Improved Properties
1个月前
已完结
Pharmacology and Pharmacokinetics of NXT007; Emicizumab-Based Engineered Fixa/Fx Bispecific Antibody with Improved Properties
1个月前
已关闭
Computational optimization of antibody humanness and stability by systematic energy-based ranking
1个月前
已完结
Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
2个月前
已完结
A novel anti-HER2/EGFR bispecific antibody–drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
2个月前
已完结
没有进行任何应助
速度真快
6个月前
感谢
6个月前
无应答。【积分已退回】
9个月前
感谢
11个月前
感谢,速度真快,帮大忙了
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论